GE HealthCare Technologies (GEHC) Return on Capital Employed (2023 - 2026)
GE HealthCare Technologies (GEHC) posted Return on Capital Employed of 9.3% for Q1 2026, down 7.74% on a QoQ basis from 10.08% in Q4 2025, and down 3185.0% year-over-year from 0.3% in Q1 2025.
GE HealthCare Technologies (GEHC) Return on Capital Employed (2023 - 2026) Analysis & Trends
GE HealthCare Technologies' Return on Capital Employed history runs 4 years deep, the most recent figure standing at 9.3% for Q1 2026.
- Quarterly Return on Capital Employed fell 3185.0% year-over-year to 9.3% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.3% (down 3185.0% YoY) and the FY2025 annual result came in at 10.67%, down 63.0% from the prior year.
- Return on Capital Employed was 9.3% for Q1 2026 at GE HealthCare Technologies, down from 10.08% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 41.15% in Q1 2025 and bottomed at 9.3% in Q1 2026.
- A 4-year average of 14.62% and a median of 10.39% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2025 — Return on Capital Employed jumped 3086 bps — and 2026, when it plunged 3185 bps.
- GE HealthCare Technologies' Return on Capital Employed stood at 10.39% in 2023, then gained by 6 bps to 10.97% in 2024, then dropped by 8 bps to 10.08% in 2025, then decreased by 8 bps to 9.3% in 2026.
- Business Quant data shows GEHC's Return on Capital Employed at 9.3% in Q1 2026, 10.08% in Q4 2025, and 10.63% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 11.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.30% |
| Dec 31, 2025 | 10.08% |
| Sep 30, 2025 | 10.63% |
| Jun 30, 2025 | 34.41% |
| Mar 31, 2025 | 41.15% |
| Dec 31, 2024 | 10.97% |
| Sep 30, 2024 | 10.39% |
| Jun 30, 2024 | 10.35% |
| Mar 31, 2024 | 10.29% |
| Dec 31, 2023 | 10.39% |
| Sep 30, 2023 | 10.18% |
| Jun 30, 2023 | 10.09% |
| Mar 31, 2023 | 11.77% |